3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Cyclophosphamide
21
fludarabine
12
Rituximab
10
Vincristine
6
Etoposide
6
Prednisone
5
Doxorubicin
5
pembrolizumab
4
Radiotherapy
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Immunotherapy, Adoptive
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Dexamethasone
4
venetoclax
3
ibrutinib
3
Nivolumab
3
Imiquimod
3
Ifosfamide
3
Exercise
3
Biopsy
3
68Ga-pentixafor
3
fludarabine phosphate
2
daratumumab
2
Transplantation
2
Stem Cell Transplantation
2
Specimen Handling
2
Sirolimus
2
Roflumilast
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Tablets
×
Lymphoid
×
Clear all
NCT06643221
2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
100 enrolled